Winthrop Advisory Group LLC Acquires Shares of 397 Axon Enterprise, Inc. (NASDAQ:AXON)

Winthrop Advisory Group LLC bought a new position in Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 397 shares of the biotechnology company’s stock, valued at approximately $236,000.

Several other hedge funds also recently made changes to their positions in the company. Insigneo Advisory Services LLC grew its position in shares of Axon Enterprise by 1.4% in the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock worth $627,000 after acquiring an additional 22 shares in the last quarter. Menard Financial Group LLC grew its position in shares of Axon Enterprise by 0.8% in the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock worth $1,204,000 after acquiring an additional 24 shares in the last quarter. PFG Investments LLC boosted its position in Axon Enterprise by 0.6% during the 3rd quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock valued at $1,547,000 after purchasing an additional 25 shares during the period. Gladstone Institutional Advisory LLC boosted its position in Axon Enterprise by 1.6% during the 3rd quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock valued at $656,000 after purchasing an additional 26 shares during the period. Finally, Mather Group LLC. boosted its position in Axon Enterprise by 3.7% during the 3rd quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock valued at $303,000 after purchasing an additional 27 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently issued reports on AXON. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. TD Cowen started coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price on the stock. Northland Securities lifted their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Robert W. Baird lifted their target price on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Finally, Needham & Company LLC boosted their price objective on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. One investment analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $504.92.

Insider Transactions at Axon Enterprise

In related news, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total transaction of $437,980.00. Following the completion of the sale, the director now directly owns 26,259 shares of the company’s stock, valued at $11,500,916.82. This trade represents a 3.67 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of the firm’s stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the sale, the director now directly owns 2,392 shares of the company’s stock, valued at $1,631,487.52. This represents a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 51,545 shares of company stock valued at $31,159,317. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Price Performance

Shares of AXON traded down $8.97 during mid-day trading on Monday, reaching $561.03. The company had a trading volume of 60,311 shares, compared to its average volume of 660,167. Axon Enterprise, Inc. has a twelve month low of $246.99 and a twelve month high of $698.67. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company’s 50-day moving average is $607.29 and its 200-day moving average is $451.03. The company has a market capitalization of $42.78 billion, a P/E ratio of 144.97, a P/E/G ratio of 14.19 and a beta of 1.04.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.